Zobrazeno 1 - 10 of 222 pro vyhledávání: '"Paul A, Kyrle"'
1
Akademický článek
Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjects
Autor: Teresa L. Krammer, Marietta Kollars, Paul A. Kyrle, Matthias Hackl, Sabine Eichinger, Ludwig Traby
Publikováno v: Frontiers in Pharmacology, Vol 13 (2022)
Platelets are the main effectors of primary hemostasis but also cause thrombosis in pathological conditions. Antiplatelet drugs are the cornerstone for the prevention of adverse cardiovascular events. Monitoring the extent of platelet inhibition is e
Externí odkaz: https://doaj.org/article/b5b42bcdc4ab42e7903d9ee822257ea1
Zobrazit plný text záznamu
4
Akademický článek
Absorption of Direct Oral Anticoagulants in Cancer Patients after Gastrectomy
Autor: Hannah C. Puhr, Aysegül Ilhan-Mutlu, Matthias Preusser, Peter Quehenberger, Paul A. Kyrle, Sabine Eichinger, Lisbeth Eischer
Publikováno v: Pharmaceutics, Vol 14, Iss 3, p 662 (2022)
Direct oral anticoagulants (DOACs) are safe and effective in cancer patients treated for venous thromboembolism (VTE) or atrial fibrillation (AF). Gastrectomy is the treatment of choice in patients with localized upper gastrointestinal cancer. DOACs
Externí odkaz: https://doaj.org/article/42a18a395c39449f9773f1fe70caaa7b
Zobrazit plný text záznamu
5
Akademický článek
Risk of venous thromboembolism during rehabilitation of patients with spinal cord injury.
Autor: Sabine Eichinger, Lisbeth Eischer, Hana Sinkovec, Gabriela Wittgruber, Ludwig Traby, Michael Kammer, Paul A Kyrle, Oskar Steinbrecher, Herbert Kaloud, Victoria Kyrle, Hartwig Moser, Renate Wildburger
Publikováno v: PLoS ONE, Vol 13, Iss 3, p e0193735 (2018)
Patients with spinal cord injury (SCI) are at risk of thrombosis and bleeding. Data on the risks during rehabilitation are inconsistent, and thromboprophylactic strategies are heterogeneous. We aimed to evaluate the thrombotic risk and bleeding event
Externí odkaz: https://doaj.org/article/b628b174643d4f0480482bc5634df9b6
Zobrazit plný text záznamu
7
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Autor: Karin Weisser, Thomas Thiele, Andreas Greinacher, Paul A. Kyrle, Theodore E. Warkentin, Sabine Eichinger
Publikováno v: The New England Journal of Medicine
Background Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChA
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::421d325cfdd4339e46c4cfde3147af3e
https://doi.org/10.1056/nejmoa2104840
Zobrazit plný text záznamu
8
Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients
Autor: Heinz Burgmann, Ludwig Traby, Marietta Kollars, Paul A. Kyrle, Bernhard Rössler, Alexander Hermann, Thomas Staudinger, Matthias Karer, Elisabeth Lobmeyr, Sabine Eichinger, Manuel Kussmann, Peter Schellongowski, Hana Šinkovec
Publikováno v: Thrombosis and Haemostasis. 122:113-122
Objectives Pulmonary thrombus formation is a hallmark of coronavirus disease 2019 (COVID-19). A dysregulated immune response culminating in thromboinflammation has been described, but the pathomechanisms remain unclear. Methods We studied 41 adult CO
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aec46901dbd1402bd82956995fd4fb2
https://doi.org/10.1055/a-1522-4131
Zobrazit plný text záznamu
9
MicroRNA Signatures in Plasma of Patients With Venous Thrombosis: A Preliminary Report
Autor: Jessica Gabler, Oskar Steinbrecher, Marietta Kollars, José Basílio, Paul A. Kyrle, Sabine Eichinger
Publikováno v: The American Journal of the Medical Sciences. 361:509-516
Background Venous thromboembolism (VTE) is a frequent and potentially fatal disease, but its pathophysiology is incompletely understood. microRNAs (miR) dysregulate hemostatic proteins and influence thrombotic pathology by posttranscriptional regulat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8619d16c976ce8155e4c11966ad4062c
https://doi.org/10.1016/j.amjms.2020.12.002
Zobrazit plný text záznamu
10
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism:A systematic review and meta-analysis
Autor: Charlotte Bradbury, Cecilia Becattini, Toshihiko Takada, Grégoire Le Gal, Tobias Tritschler, Benilde Cosmi, Faizan Khan, Giancarlo Agnelli, Francis Couturaud, Marc A. Rodger, Clive Kearon, Geert-Jan Geersing, Gary E. Raskob, Anthonie W. A. Lensing, Sergio Siragusa, Minggao Shi, Maria Cristina Vedovati, Jeffrey I. Weitz, Gualtiero Palareti, Ranjeeta Mallick, Kednapa Thavorn, Lisbeth Eischer, Sabine Eichinger, Cristina Legnani, Philip S. Wells, Paul A. Kyrle, Miriam Kimpton, Martin Gebel, Walter Ageno, Paolo Prandoni, Sameer Parpia, Dean Fergusson, Michael A. Grosso, Harry R. Büller, Antonio Palla, Letizia Marconi, Drahomir Aujesky, Brian Hutton
Publikováno v: Khan, F, Bradbury, C A, Fergusson, D & al., E 2021, ' Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism : A systematic review and meta-analysis ', Journal of Thrombosis and Haemostasis, vol. 19, no. 11, pp. 2801-2813 . https://doi.org/10.1111/jth.15491
Journal of thrombosis and haemostasis, 19(11), 2801-2813. Wiley-Blackwell
Background: The long-term risk for recurrent venous thromboembolism (VTE) during extended anticoagulation for a first unprovoked VTE is uncertain. Objectives: To determine the incidence of recurrent VTE during extended anticoagulation of up to 5years
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f3c4cf561233458e08b474421a5887
https://hdl.handle.net/1983/9379f44f-8ec1-4a74-94c7-cf06bbca1b12
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje